BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10485151)

  • 1. The impact of comorbidity and age on survival with laryngeal cancer.
    Sabin SL; Rosenfeld RM; Sundaram K; Har-el G; Lucente FE
    Ear Nose Throat J; 1999 Aug; 78(8):578, 581-4. PubMed ID: 10485151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
    Castro MA; Dedivitis RA; Ribeiro KC
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection.
    Wang CY; Lin YS; Tzao C; Lee HC; Huang MH; Hsu WH; Hsu HS
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):877-81. PubMed ID: 17920921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The age-adjusted Charlson Comorbidity Index as an outcome predictor of patients with acute mesenteric ischemia.
    Marchena-Gomez J; Acosta-Merida MA; Hemmersbach-Miller M; Conde-Martel A; Roque-Castellano C; Hernandez-Romero J
    Ann Vasc Surg; 2009; 23(4):458-64. PubMed ID: 19128926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year survival rates and time trends of laryngeal cancer in the US population.
    Cosetti M; Yu GP; Schantz SP
    Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of local failure in early laryngeal cancer.
    Lohynska R; Slavicek A; Bahanan A; Novakova P
    Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
    Birim O; Kappetein AP; Goorden T; van Klaveren RJ; Bogers AJ
    Ann Thorac Surg; 2005 Sep; 80(3):1021-6. PubMed ID: 16122477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
    Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
    J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does Charlson-comorbidity index correlate with short-term outcome in patients with gastric cancer?].
    Lübke T; Mönig SP; Schneider PM; Hölscher AH; Bollschweiler E
    Zentralbl Chir; 2003 Nov; 128(11):970-6. PubMed ID: 14669119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
    Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
    J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of comorbidity in salivary gland carcinoma.
    Terhaard CH; van der Schroeff MP; van Schie K; Eerenstein SE; Lubsen H; Kaanders JH; Smeele LE; Burlage FR; van Den Ende PL; Baatenburg de Jong RJ
    Cancer; 2008 Oct; 113(7):1572-9. PubMed ID: 18704992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prognostic relevance of age and comorbidity in patients with resected gastric cancer].
    Bollschweiler E; Breckheimer S; Mönig SP; Hölscher AH
    Zentralbl Chir; 2009 Feb; 134(1):71-6. PubMed ID: 19242886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study.
    Lund L; Jacobsen J; Nørgaard M; McLaughlin JK; Blot WJ; Borre M; Sørensen HT
    J Urol; 2009 Jul; 182(1):35-40; discussion 40. PubMed ID: 19450859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mediterranean age-comorbidity prognostic index for survival in dialysis populations.
    Fernandez Lucas M; Teruel JL; Zamora J; Lopez Mateos M; Rivera M; Ortuno J
    J Nephrol; 2007; 20(6):696-702. PubMed ID: 18046672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
    Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
    Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.